Ranbaxy to launch Generic Diovan by Q3/Q4 CY13 end: Report

28 Aug 2013 Evaluate

Ranbaxy Laboratories is reportedly planning to launch Generic Diovan by Q3/Q4 CY (Calendar Year) 2013 end. Generic Diovan has market sales of $2 billion in US. The company had applied for USFDA nod for Diovan in September 12.

Ranbaxy Laboratories, India’s largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×